Digestive symptoms, such as diarrhea and anorexia, are common in COVID-19 patients. Almost 50% of coronavirus patients from the Hubei province of China presented digestive symptoms and cited them as their main symptoms.
With COVID-19 testing limited, we don't have enough data on the virus to know how widespread the diseases will ultimately become, or how long social distancing measures will last.
Researchers have analyzed the potential outcomes of public health measures on slowing and suppressing the spread of COVID-19.
Researchers are pushing for the development of an instant mobile app that will alert people who have come into contact with a COVID-19 patient to immediately isolate themselves via an instant message. If rapidly and widely developed, the app could significantly help to contain the spread of coronavirus.
Undetected and undocumented cases of COVID-19 were largely responsible for the rapid spread of the virus in China. 86% of all infections were undocumented before the January 23 Wuhan travel shutdown. Per person, the undocumented infections were half as contagious as documented infections but were the source of two-thirds of documented infections.
SARS-CoV-2 is detectable in aerosols for up to three hours and up to four hours on copper. On cardboard, the virus is detectable for up to 24 hours, and up to three days on plastic and stainless steel. The study suggests the virus may be acquired through the air in addition to touching surfaces.
Australian researchers have mapped immune responses from one of the country's first COVID-19 patients. The findings shed light on how the immune system fights the virus and assists in recovery from the virus.
Researchers who have been studying the coronavirus since the outbreak say the US had an opportunity to be well ahead of the game when it came to COVID-19. However, problems with testing rollouts, regulatory guidelines, and initial flaws in early CDC tests, has left US citizens in critical danger. Rather than focusing on reacting to the pandemic, researchers say we should have focused on preparedness.
Researchers are making progress in developing potential vaccines for coronavirus infections. While a vaccine for COVID-19 might be over a year away from market, researchers are looking ahead to attempt to prevent future outbreaks.
With the peak of COVID-19 cases occurring between 3.5 to four weeks after controlled interventions were put into place in China, US researchers are urging the public to ramp up social distancing efforts and increase testing immediately.
A phase 1 trial evaluating an investigational vaccine designed to protect against COVID-19 has begun in Seattle. The study will enroll 45 healthy people aged 18 to 55, over approximately 6 weeks. The first participant received the investigational vaccine today. Adults in the Seattle area may join the study.
Johns Hopkins University researchers propose using antibodies from the plasma or serum of those who have recovered from COVID-19 to help boost the immunity of newly infected patients and for those at risk of contracting the disease. Researchers say the antibodies may bind to and neutralize SARS-CoV-2. The technique has been proven successful in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic.